Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Newspaper publication of financial results for quarter ended 31st March 2023, of the Company published today i.e.12th May,2023, in Business Standard and Sakal. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation made to the Investors / Analysts Call and the same is also being uploaded on the website of the Company. The recording and transcript of the Call thereof will be uploaded, in due course on the website of the Company at Announcements & Stock Exchange Disclosures - Sanofi in India (sanofiindialtd.com)
Set for demerger, Sanofi's consumer health brands have strong traction
Company says split will allow it to unlock business potential in pharmaceuticals and consumer healthcare
Sanofi India to demerge consumer health biz into a wholly-owned subsidiary
Sanofi Consumer Healthcare India is expected to be listed on both the BSE and NSE, the company said in an exchange notification Sanofi India Ltd - 500674 - Results- Unaudited Financial Results For Quarter Ended 31St March 2023
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the Unaudited Financial Results for the quarter ended 31st March 2023 approved at today''s Board Meeting with a copy of the Limited Review Report duly signed by the Auditors of the Company Sanofi India Ltd - 500674 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the Unaudited Financial Results for the quarter ended 31st March 2023 approved at the Meeting held today with a copy of the Limited Review Report duly signed by the Auditors of the Company Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
The Board of Directors of Sanofi India Limited, at its meeting held today, has approved a scheme of arrangement under Sections 230 to 232 of the Companies Act, 2013, to demerge its Consumer Healthcare Business from the Demerged Company into its wholly-owned subsidiary Sanofi Consumer Healthcare India Limited (currently under the process of incorporation) ('SCHIL /Resulting Company'). The detailed disclosures pertaining to the Scheme are captured in the attachment. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor / analysts call on Financial Results of Q1 for the Financial Year 2023 on 11th May 2023 at 11:00 a.m. Kindly refer to the attachment for details of the call. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced.